CAPTRUST Financial Advisors
MBIO icon

CAPTRUST Financial Advisors’s Mustang Bio MBIO Stock Holding History

CAPTRUST Financial Advisors’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1
Closed -$1K – 3213
2022
Q2 		$1K Hold
1
– – ﹤0.01% 4695
2022
Q1 		$1K Buy
+1
New +$822 ﹤0.01% 4710

Other funds holding MBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CAPTRUST Financial Advisors's MBIO Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Mustang Bio (MBIO) in Q3 2022, closing a stake of 1 share — an estimated $1K sold.

CAPTRUST Financial Advisors first reported a position in MBIO in Q1 2022 and held it in 2 quarters. The position peaked at $1K in Q2 2022. 67 funds tracked by Wall St. Rank hold MBIO as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Mustang Bio position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 1 Mustang Bio share in Q3 2022, an estimated $1K.
  • CAPTRUST Financial Advisors first reported a position in Mustang Bio in Q1 2022 and held it in 2 quarters.
  • CAPTRUST Financial Advisors's Mustang Bio position peaked at $1K in Q2 2022.
  • 67 funds tracked by Wall St. Rank held Mustang Bio as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.